At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 38 enrolled
Drug / intervention
Yigansan +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Efficacy and Safety of Yi-Gan San in Children and Adolescents With Tourette's Disorder
In Brief
A Phase 2 clinical trial evaluating Yigansan and Placebo for Tourette Disorder and Tic Disorders. Completed, enrolled 38 participants across 1 site.
Detailed Summary
Yigansan was used in Ming dynasty by Xue Kai as a remedy for restlessness and agitation in children. We expect that the total YGTSS scores of Yigansan-treated subjects will be significantly reduced compared to that of placebo-treated subjects.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTourette Disorder, Tic Disorders
CountriesTaiwan
Collaborators--
Timeline
Phase 2CompletedFinished
20192020202120222023202420252026
Enrollment StartJun 2018
First PostedJun 2018
Primary CompletionAug 2020
Study CompletionAug 2022
TodayJul 2026
First PostedJun 20, 2018
Enrollment StartJun 16, 2018
Primary CompletionAug 15, 2020
Study CompletionAug 31, 2022
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 8.0 years ago
Interventions
Yigansandrug
Yigansan granules
Placebodrug
One-tenth concentration of Yigansan manufactured to mimic Yigansan granules